$70.47
2.313.39%
At Close: -
$70.56
0.090.13%
After Hours: Sep 20, 7:39 PM EDT
15 minutes delayed
Viking Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Viking Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-07-24 | $-0.20 | $-0.27 | 25.9 % |
Mar 2024 | 2024-04-24 | $-0.26 | $-0.28 | 7.14 % |
Dec 2023 | 2024-02-07 | $-0.25 | $-0.26 | 3.85 % |
Sep 2023 | 2023-10-25 | $-0.23 | $-0.22 | -4.55 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Viking Therapeutics (VKTX) is scheduled to report earnings on October 23, 2024. The last reported earnings were for reported on July 24, 2024 for Q2.
The Actual EPS was $-0.20, which beat the estimate of $-0.27.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.